5-Feb-2025
AI tool helps find life-saving medicine for rare disease
University of Pennsylvania School of MedicinePeer-Reviewed Publication
Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication identified by an AI-guided analysis
- Journal
- New England Journal of Medicine
- Funder
- NIH/National Heart, Lung and Blood Institute, Food and Drug Administration, NIH/National Center for Advancing Translational Sciences (NCATS), Advanced Research Projects Agency for Health, Castleman Disease Collaborative Network, NCATS Biomedical Data Translator Initiative, Chan Zuckerberg Initiative, Lyda Hill Philanthropies, Arnold Ventures, Elevate Prize Foundation, Carolyn Smith Foundation, Every Cure, Bioaegis